Substance Use Disorder Statistics for Postpartum (0-12 months)

The postpartum period, the first 12 months after childbirth, is a time of profound physical and emotional change. New mothers face a unique combination of stressors, including hormonal shifts, sleep deprivation, and the immense responsibility of caring for a newborn, which can trigger or worsen substance misuse^[2]. Research consistently shows that postpartum depression and anxiety are strong predictors of substance misuse, creating a cycle that can be difficult to break without support^[5]. Understanding the prevalence and context of this issue is the first step toward developing effective interventions and support systems for mothers and their families.

Substance use disorders rarely exist in isolation during the postpartum period. Research consistently shows that postpartum depression and anxiety are strong predictors of substance misuse^[5]. Many new mothers turn to substances as a way to cope with overwhelming symptoms of depression, anxiety, or trauma related to childbirth^[14]. This co-occurrence creates a dangerous cycle where each condition can exacerbate the other, making integrated treatment essential. According to a 2022 SAMHSA survey, 18% of postpartum women reported experiencing both depression and a substance use disorder simultaneously^[16].

The connection between postpartum mental health and substance use is profound. Mothers experiencing depressive symptoms are significantly more likely to use substances as a coping mechanism. This co-occurrence not only complicates diagnosis and treatment but also amplifies the risks for both the mother and child. The data reveals a stark difference in substance use patterns between mothers with and without depressive symptoms, underscoring the importance of integrated care that addresses both conditions simultaneously^[2]. In fact, 18% of postpartum women reported experiencing both depression and substance use disorder simultaneously^[16].

While overall substance use is a concern, data from healthcare settings reveals which specific substance use disorders are most commonly diagnosed among pregnant and postpartum women. Nicotine use disorder is the most frequent diagnosis in both emergency and inpatient settings, followed by cannabis and opioid use disorders. These figures, captured during healthcare encounters, provide a clinical snapshot of the challenges this population faces and help guide targeted prevention and treatment efforts.

Data from hospital settings provide a clearer picture of the specific types of substance use disorders affecting pregnant and postpartum women. When these women seek care in emergency departments or are admitted as inpatients, diagnoses often reveal high rates of nicotine, cannabis, and opioid use. These statistics are vital for healthcare systems to understand the scope of the problem and allocate resources for screening, intervention, and specialized care programs within clinical environments.

Despite the clear need, a majority of postpartum women with SUD do not receive care. A significant treatment gap exists where nearly 65% of this population receives no intervention at all^[8]. This gap is driven by powerful barriers, including the stigma and cultural misconceptions surrounding mental illness and addiction^[18]. Many new mothers fear negative child welfare implications if they seek help, creating an environment where substance misuse is hidden and untreated^[28]. Structural barriers like lack of childcare, inadequate insurance, and poor access to mental health counseling further worsen the risk, especially in low-income or minority communities^[29].

Despite the clear need, a significant portion of postpartum women with SUD do not receive help. A major barrier is the pervasive stigma surrounding mental illness and addiction, which can prevent individuals from seeking care^[18]. Many new mothers fear negative legal consequences or the involvement of child welfare services if they disclose their substance use, leading to an environment where the issue remains hidden and untreated^[28]. Systemic issues, including inadequate screening during postpartum visits and a shortage of integrated treatment programs, further contribute to this critical gap in care^[37].

For postpartum women with opioid use disorder (OUD), accessing care can be particularly challenging. A secret-shopper study in Florida highlighted significant systemic barriers for Medicaid-enrolled patients. The study revealed difficulties in simply reaching a provider, low rates of Medicaid acceptance, and outright denial of appointments for pregnant women, illustrating a healthcare system that is often ill-equipped to handle the needs of this vulnerable population.

For postpartum women with opioid use disorder (OUD), accessing care is particularly challenging. A 'secret-shopper' study revealed significant hurdles for Medicaid-enrolled patients trying to connect with providers. Many calls do not reach a provider, and even when they do, acceptance rates for Medicaid are low. These systemic barriers disproportionately affect low-income mothers and can prevent them from receiving life-saving medications for opioid use disorder (MOUD), such as buprenorphine.

Certain populations are disproportionately affected by postpartum substance use and related mental health conditions. Factors such as age, marital status, race, insurance coverage, and pre-existing health conditions play a significant role in a new mother's risk profile^[15]. Socioeconomic status is also a critical determinant, as income inequality, lack of childcare, and fragmented insurance coverage can worsen SUD risk, particularly in low-income and minority communities^[40]. Understanding these disparities is essential for creating equitable and targeted support systems.

Untreated postpartum substance use and co-occurring mental health disorders have serious, long-lasting consequences for both mothers and their children. For mothers, these conditions can lead to chronic mental health issues, increased risk of self-harm, and lower quality of life^[12]. For infants, maternal mental health challenges can disrupt bonding and are associated with impaired growth, poorer neurodevelopmental outcomes in motor and cognitive skills, and sleep disturbances^[12]. These impacts highlight the critical importance of timely and effective treatment.

The landscape of postpartum mental health has been shifting. Prior to 2020, data showed a gradual increase in substance misuse among women of reproductive age^[28]. The onset of the COVID-19 pandemic exacerbated these trends, with studies noting a marked increase in anxiety, depression, and isolation among new mothers^[44]. This led to a significant rise in substance use frequency and binge patterns, with some studies indicating a 1.5-fold increase over pre-pandemic rates^[45]. At the same time, awareness and diagnosis of conditions like postpartum depression have also been on the rise.

While this page focuses on the postpartum period, data from other high-stress populations can provide valuable context. Groups like first responders, military veterans, and LGBTQ+ individuals also face high rates of mental health conditions and substance use, often driven by similar factors of trauma, stress, and stigma. For example, military culture's value on stoicism can create barriers to care^[46], similar to how new mothers fear judgment. Likewise, concerns about discrimination prevent many LGBTQ+ individuals from seeking necessary treatment^[47]. These parallels highlight the universal need for destigmatized, accessible, and culturally competent care.